1,332
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Comparison of intraluminal radiofrequency ablation and stents vs. stents alone in the management of malignant biliary obstruction

ORCID Icon, , , , , & show all
Pages 853-861 | Received 01 Jan 2017, Accepted 18 Mar 2017, Published online: 10 Apr 2017

References

  • Sawas T, Al Halabi S, Parsi MA, Vargo JJ. (2015). Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc 82:256–67.
  • Kahaleh M, Tokar J, Conaway MR, et al. (2005). Efficacy and complications of covered Wallstents in malignant distal biliary obstruction. Gastrointest Endosc 61:528–33.
  • Moss AC, Morris E, Leyden J, MacMathuna P. (2007). Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev 33:213–21.
  • Sangchan A, Kongkasame W, Pugkhem A, et al. (2012). Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial. Gastrointest Endosc 76:93–9.
  • Loew BJ, Howell DA, Sanders MK, et al. (2009). Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial. Gastrointest Endosc 70:445–53.
  • Li Z, Zhang K, Lin SM, et al. (2016). Radiofrequency ablation combined with percutaneous ethanol injection for hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia. [Epub ahead of print]. doi: 10.1080/02656736.2016.1237681.
  • Cheng M, Fay M, Steinke K. (2016). Percutaneous CT-guided thermal ablation as salvage therapy for recurrent non-small cell lung cancer after external beam radiotherapy: a retrospective study. Int J Hyperthermia 32:316–23.
  • Liu M, Huang GL, Xu M, et al. (2017). Percutaneous thermal ablation for the treatment of colorectal liver metastases and hepatocellular carcinoma: a comparison of local therapeutic efficacy. Int J Hyperthermia. [Epub ahead of print]. doi: 10.1080/02656736.2017.1278622.
  • Zoepf T, Jakobs R, Arnold JC, et al. (2005). Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol 100:2426–30.
  • Vavra P, Dostalik J, Zacharoulis D, et al. (2009). Endoscopic radiofrequency ablation in colorectal cancer: initial clinical results of a new bipolar radiofrequency ablation device. Dis Colon Rectum 52:355–8.
  • Tuttle R, Nurkin SJ, Hochwald SN. (2014). Ablative therapy for esophageal dysplasia and early malignancy: focus on RFA. Biomed Res Int 2014:642063.
  • Steel AW, Postgate AJ, Khorsandi S, et al. (2011). Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc 73:149–53.
  • Wu T, Li H, Li W, et al. (2015). Percutaneous intraluminal radiofrequency ablation for malignant extrahepatic biliary obstruction: a safe and feasible method. Dig Dis Sci 60:2158–63.
  • Dolak W, Schreiber F, Schwaighofer H, et al. (2014). Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications. Surg Endosc 28:854–60.
  • Monga A, Gupta R, Ramchandani M, et al. (2011). Endoscopic radiofrequency ablation of cholangiocarcinoma: new palliative treatment modality (with videos). Gastrointest Endosc 74:935–7.
  • Liberato MJ, Canena JM. (2012). Endoscopic stenting for hilar cholangiocarcinoma: efficacy of unilateral and bilateral placement of plastic and metal stents in a retrospective review of 480 patients. BMC Gastroenterol 12:103.
  • Figueroa-Barojas P, Bakhru MR, Habib NA, et al. (2013). Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique. J Oncol 2013:1–5.
  • Mizandari M, Pai M, Xi F, et al. (2013). Percutaneous intraductal radiofrequency ablation is a safe treatment for malignant biliary obstruction: feasibility and early results. Cardiovasc Inter Rad 36:814–19.
  • Wadsworth CA, Westaby D, Khan SA. (2013). Endoscopic radiofrequency ablation for cholangiocarcinoma. Curr. Opin. Gastroenterol 29:305–11.
  • Tal AO. (2014). Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction. World J Gastrointest Endosc 6:13.
  • Pai M, Valek V, Tomas A, et al. (2014). Percutaneous intraductal radiofrequency ablation for clearance of occluded metal stent in malignant biliary obstruction: feasibility and early results. Cardiovasc Inter Rad 37:235–40.
  • Li TF, Huang GH, Li Z, et al. (2015). Percutaneous transhepatic cholangiography and intraductal radiofrequency ablation combined with biliary stent placement for malignant biliary obstruction. J Vasc Interv Radiol 26:715–21.
  • Kallis Y, Phillips N, Steel A, et al. (2015). Analysis of endoscopic radiofrequency ablation of biliary malignant strictures in pancreatic cancer suggests potential survival benefit. Dig Dis Sci 60:3449–55.
  • Sharaiha RZ, Natov N, Glockenberg KS, et al. (2014). Comparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictures: is there an added benefit? Dig Dis Sci 59:3099–102.
  • Oken MM, Creech RH, Tormey DC, et al. (1982). Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–55.
  • Mensah ET, Martin J, Topazian M. (2016). Radiofrequency ablation for biliary malignancies. Curr Opin Gastroenterol 32:238–43.
  • Sarkisian AM, Andalib I, Kumta NA, Sharaiha RZ. (2016). Radiofrequency ablation for pancreatobiliary disease. Curr Opin Gastroenterol. [Epub ahead of print]. doi: 10.1097/MOG.0000000000000300.
  • De Palma GD, Pezzullo A, Rega M, et al. (2003). Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study. Gastrointest Endosc 58:50–3.
  • Sacks D, McClenny TE, Cardella JF, Lewis CA. (2003). Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14:S199–S202.
  • Paik WH, Park YS, Hwang JH, et al. (2009). Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc 69:55–62.
  • Isayama H, Hamada T, Yasuda I, et al. (2015). TOKYO criteria 2014 for transpapillary biliary stenting. Dig Endosc 27:259–64.
  • Singh S, Repaka R. (2016). Temperature-controlled radiofrequency ablation of different tissues using two-compartment models. Int J Hyperthermia. [Epub ahead of print]. doi: 10.1080/02656736.2016.1223890.
  • Gerges C, Schumacher B, Terheggen G, Neuhaus H. (2011). Expandable metal stents for malignant hilar biliary obstruction. Gastrointest Endosc Clin N Am 21:481–97.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.